I**ntroduction** {#s1}
================

Exchange of material between organelles is largely mediated by transport vesicles, which bud from the surface of a donor compartment through the mechanical action of protein coats and fuse with an acceptor compartment through the action of SNARE proteins ([@bib7]). Between these two elementary steps, various protein machineries control the fate of transport vesicles. These include molecular motors for long-range transport and tethering complexes, which trap vesicles in the vicinity of their destination organelle ([@bib10]).

Golgins are long coiled-coil proteins at the surface of the Golgi apparatus. Through their string-like structure whose length might approach 300 nm, they have been proposed to form a matrix to tether transport vesicles in the vicinity of Golgi cisternae, while excluding some large particles such as ribosomes ([@bib35]; [@bib8]; [@bib38]; [@bib53]; [@bib21]). In addition, recent work based on the artificial attachment of golgins to mitochondria indicates that golgins provide a first layer of vesicle selectivity ([@bib54]). Golgins that are normally anchored on the *cis* side of the Golgi preferentially capture vesicles trafficking between the endoplasmic reticulum (ER) and the *cis* Golgi, whereas those that are normally anchored at the *trans* side preferentially capture vesicles from endosomal sources. Although the molecular determinants responsible for this selectivity are not well known, discrete binding sites for Rab proteins have been identified along the coiled-coils of golgins, suggesting a mechanism by which vesicles move within the golgin matrix by transient Rab-coiled-coil contacts ([@bib46]). EM and atomic force microscopy show that the coiled-coil architecture of golgins is interrupted by regions of high flexibility, which might facilitate the movement of trapped vesicles ([@bib13]; [@bib28]).

Stereospecific interactions between proteins and lipids have an undisputed role in membrane traffic. However, other factors related to bulk physicochemical properties of membranes such as membrane curvature, electrostatics and lipid packing also play a role ([@bib4]). In the case of vesicle tethering at the Golgi, Kobayashi and Pagano reported in 1988 a puzzling observation ([@bib30]). When liposomes made of pure lipids were incubated with perforated cells, they bound almost exclusively to the Golgi and not to any other organelle. Binding was fast, occurred at 4°C, did not require ATP, and was observed with simple lipid compositions such as pure egg phosphatidylcholine (PC). In the presence of ATP and at temperature above 15°C, liposome binding was followed by membrane fusion and delivery of the liposome content to the Golgi. Interestingly, the authors noticed that liposomes with a small radius (R \< 40 nm) were targeted more efficiently to the Golgi than larger ones ([@bib30]). Together, these observations suggest that the Golgi has a superior ability to capture small vesicles than any other organelle because of an unexplained avidity for curved lipid membranes.

We previously presented a minimal model for vesicle tethering by the golgin GMAP-210, in which non stereospecific protein-membrane interactions play a predominant role ([@bib18]). GMAP-210, which controls vesicle traffic at the *cis* side of the Golgi ([@bib43]), contains an N-terminal ALPS motif \[1--38\], several long coiled-coil regions, a GRAB domain \[1774--1843\], and a region of low complexity \[1844--1979\]. ALPS motifs are amphipathic helices that adsorb preferentially onto highly curved membranes containing unsaturated lipids ([@bib17]; [@bib16]; [@bib2]). The GRAB domain interacts with membrane-bound Arf1-GTP ([@bib22]). Because the Arf1 regulator ArfGAP1, which hydrolyzes GTP on Arf1, also contains an ALPS motif, the interaction between the GRAB domain and Arf1-GTP is not stable on curved membranes ([@bib18]). Consequently, GMAP-210 tethers small liposomes through its ALPS motif to flatter membranes through its GRAB domain, but other geometrical combinations are not possible ([@bib18]). In a cellular context, this model suggests that GMAP-210 connects transport vesicles to Golgi cisternae on the basis of their contrasting membrane curvature.

Despite some predictions of this model have been successfully tested in cells, notably the relative contribution of the ALPS motif and of the GRAB domain to vesicle *versus* cisternae binding ([@bib11]; [@bib44]), several major questions remain. First, does GMAP-210 account for the striking avidity of the Golgi for small liposomes? In other words, is GMAP-210 a major vesicle trap? Second, are the amphipathic properties of the ALPS motif of GMAP-210 sufficient to explain the selective tethering of the vesicles of the early secretory pathway at the cis-Golgi as opposed to other transport vesicles?

In this study, we first connect the avidity of the Golgi for small liposomes with the biochemical properties of the golgin GMAP-210. Second, we interrogate the binding mode of the ALPS motif of GMAP-210 in a cellular context by extensive mutagenesis. We observe that the ALPS motif is very permissive to mutations that should disrupt stereospecific interactions, but is supersensitive to mutations that modify its amphipathic character. Notably, the sparse distribution of hydrophobic residues along the ALPS sequence is key for vesicle recognition. We conclude that the ALPS motif of GMAP-210 acts as a filter at the entrance of the *cis* Golgi to select transport vesicles of the early secretory pathway based on their small size and high content in unsaturated lipids.

R**esults** {#s2}
===========

Avidity of the Golgi for small liposomes containing monounsaturated lipids {#s2-1}
--------------------------------------------------------------------------

The Kobayashi-Pagano experiment consists of peeling the upper membrane of cultured cells with a filter followed by incubating the resulting open cells with synthetic fluorescent liposomes ([@bib30]). After several washes with medium, the cells are examined with a fluorescent microscope ([Figure 1A,B](#fig1){ref-type="fig"}). In pilot experiments, we observed the same effects as those previously reported. Liposomes made of PC bound almost exclusively to the Golgi apparatus. In addition, the extent of binding was higher with small liposomes prepared by sonication than with larger liposomes prepared by extrusion ([Figure 1B](#fig1){ref-type="fig"}).10.7554/eLife.16988.002Figure 1.Preference of the Golgi for small unsaturated liposomes and biochemical properties of GMAP-210 ALPS motif.(**A**) Principles of the Kobayashi-Pagano experiment. (**B**) Typical observations. RPE1 cells stably expressing Rab6-GFP were perforated and incubated with DOPC liposomes (labeled with 1 mol% Rhod-PE). The liposomes were prepared by sonication or by extrusion through 200 nm (diameter) filters. The actual liposome radius (Rh) is indicated. Images were acquired with an epifluorescence microscope. (**C**, **D**) Experiments similar to that shown in (**B**) with liposomes of defined composition (**C**) or size (**D**). In (**C**) all liposomes were obtained by extrusion through 30 nm filters. In (**D**) all liposomes were used at a concentration of 250 µM lipids. The liposome fluorescence intensity in the Golgi area was determined. Each point corresponds to one cell from two to three independent experiments. (**E**) Domain organization of GMAP-210 and minimal model for membrane tethering ([@bib18]). (**F**) Effects of membrane curvature and lipid unsaturation on the binding of the N-ter region of GMAP-210 to liposomes. Liposome binding was determined by monitoring the NBD fluorescence intensity. The plot shows the effect of liposome size and unsaturation from two independent experiments (triangles and inverted triangles). The fluorescence in solution was set at 1. Bars: 10 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.16988.002](10.7554/eLife.16988.002)10.7554/eLife.16988.003Figure 1---figure supplement 1.Liposome tethering properties of perforated cells.Large fields of RPE1 cells stably expressing Rab6-GFP after perforation and incubation with DOPC liposomes (extrusion 200 nm or 30 nm). Scale bars: 10 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.16988.003](10.7554/eLife.16988.003)10.7554/eLife.16988.004Figure 1---figure supplement 2.Cumulative effects of membrane curvature and lipid unsaturation on the binding of the N-ter region of GMAP-210 to liposomes.Fluorescence spectra of mixtures containing 0.125 µM NBD-labeled GMAP-210 (fragment \[1--375\]) and liposomes (150 µM lipids) of the indicated size and composition. The fluorescence intensity at 540 nm was measured to build the plot of [Figure 1F](#fig1){ref-type="fig"}.**DOI:** [http://dx.doi.org/10.7554/eLife.16988.004](10.7554/eLife.16988.004)

To perform a more comprehensive and quantitative analysis, we applied increasing amounts of liposomes of defined size and composition to perforated cells and established saturation curves ([Figure 1C,D](#fig1){ref-type="fig"} and [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). The liposomes contained trace amounts of a red fluorescent lipid (Rhod-PE), whereas the cells stably expressed Rab6-GFP in order to visualize the Golgi area ([Figure 1B](#fig1){ref-type="fig"}). All experiments were performed with no ATP in the medium to minimize liposome fusion. We observed that liposome binding increased strongly with the unsaturation level of PC. Binding was maximal with PC containing two unsaturated acyl chains (C18:1-C18:1-PC = DOPC), barely detectable with PC containing two saturated acyl chains (C14:0-C14:0-PC = DMPC), and intermediate with PC containing one saturated and one monounsaturated acyl chain (C16:0-C18:1-PC = POPC) ([Figure 1C](#fig1){ref-type="fig"}). Moreover, liposome size had a strong effect on Golgi binding ([Figure 1D](#fig1){ref-type="fig"}). Below 50 nm in radius, liposomes bound significantly to the Golgi; above this radius, liposome binding was close to background levels. By calibrating the fluorescence intensity as a function of liposome concentration, we estimated that hundreds of small DOPC liposomes were trapped in the Golgi region of each perforated cell (see Materials and methods).

GMAP-210 contributes to the liposome avidity of the Golgi {#s2-2}
---------------------------------------------------------

The cumulative effects of membrane curvature and lipid unsaturation on the binding of liposomes to the Golgi was reminiscent of the biochemical properties of ALPS motifs, which are present in various proteins ([@bib5]; [@bib17]; [@bib50]). In the case of GMAP-210, the ALPS motif is present at the N-terminus of the golgin, which makes it ideally positioned to capture small transport vesicles or, in the case of perforated cells, small liposomes ([Figure 1E](#fig1){ref-type="fig"}).

The membrane binding properties of the ALPS motif of GMAP-210 have not been characterized as thoroughly as those of the ALPS motifs of ArfGAP1 ([@bib5]; [@bib37]; [@bib50]). We used a NBD-labeled form of the N-terminal region \[1--375\] of GMAP-210 ([@bib41]) and conducted binding experiments with liposomes similar to those used on perforated cells except that they lacked fluorescent lipids. The increase in NBD fluorescence resulting from the adsorption of the ALPS motif onto the liposome surface was used as an index of membrane binding ([@bib17]; [@bib41]). The N-terminal region of GMAP-210 showed a sharp preference for liposomes combining high curvature and high content of monounsaturated lipids ([Figure 1F](#fig1){ref-type="fig"} and [Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}).

Given the good match between the liposome-binding properties of the Golgi and that of GMAP-210 in vitro, we surmised that GMAP-210 could contribute to the liposome trapping properties of the Golgi. To test this hypothesis, we reduced GMAP-210 expression using two recently described siRNA ([@bib43]). With both siRNA, the amount of GMAP-210 decreased ≈ seven-fold whereas the liposome tethering capacity of the Golgi decreased 2.5-fold ([Figure 2A](#fig2){ref-type="fig"} and [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}). In addition, we characterized the perforated cells by immunofluorescence. We observed good colocalization between the trapped liposomes and anti GMAP-210 or anti GM130 antibodies ([Figure 2B](#fig2){ref-type="fig"}). After treatment with siRNA against GMAP-210, the cells that showed background levels of GMAP-210 showed barely any significant liposome staining at the Golgi ([Figure 2B](#fig2){ref-type="fig"}). Altogether, the experiments shown in [Figure 2](#fig2){ref-type="fig"} indicate that GMAP-210 makes a major contribution to the liposome capture property of the Golgi.10.7554/eLife.16988.005Figure 2.GMAP-210 is responsible for the ability of the Golgi to capture liposomes.(**A**) RPE1 cells were treated with siRNA against GMAP-210 or with control siRNA. After 72 hr, the cells were perforated and small DOPC liposomes (250 µM lipids), which were obtained by extrusion through 30 nm polycarbonate filters, were applied. Liposome capture was quantified as in [Figure 1](#fig1){ref-type="fig"}. The western blot shows the amount of GMAP-210 in the siRNA-treated cells. (**B**) Immunofluorescence characterization of RPE1 cells after treatment with anti GMAP-210 siRNA or control siRNA followed by perforation and incubation with small DOPC liposomes obtained by extrusion. The actual liposome radius is indicated. The images show one Z section as obtained in a confocal microscope. The profiles show the fluorescence intensity of the three markers along the horizontal lines as indicated in the merged images. Bars: 10 µm. Error bars: SEM (n = 4)**DOI:** [http://dx.doi.org/10.7554/eLife.16988.005](10.7554/eLife.16988.005)10.7554/eLife.16988.006Figure 2---figure supplement 1.GMAP-210 is responsible for the ability of the Golgi to capture liposomes.(**A**) RPE1 cells were treated with siRNA against GMAP-210 or with control siRNA. After 72 hr, the cells were perforated and small DOPC liposomes (250 µM lipids), which were obtained by extrusion through 30 nm polycarbonate filters, were applied. (**B**) Quantification of liposome capture from 4 independent experiments similar to (**A**). (**C**) Western blot analysis of the siRNA-treated cells. The data shown in (**B**) and (**C**) were used to build the bar plots shown in [Figure 2A](#fig2){ref-type="fig"}. Scale bars: 10 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.16988.006](10.7554/eLife.16988.006)

To further assess the role of GMAP-210 in the liposome tethering properties of the Golgi, we combined a golgin derouting strategy ([@bib54]) with the use of perforated cells ([@bib30]). The cells expressed two constructs ([Figure 3A](#fig3){ref-type="fig"}). The first contained the following regions: the ALPS motif of GMAP-210 \[1--38\] to capture small liposomes, an artificial coiled-coil (ACC1) to impose a dimeric architecture ([@bib25]), a green fluorescent protein (GFP) for visualization, and a FK binding protein (FKBP) for control by rapamycin. The second construct, Mito-FRB, enabled the mitochondria attachment of the first construct by rapamycin-induced dimerization ([@bib54]; [@bib44]). In addition, we treated the cells with nocodazole, which, by disrupting the microtubules, causes the Golgi to disperse into mini stacks in the cytoplasm. This condition was chosen to increase the probability of liposome exchange between the mitochondria and the Golgi as observed in the case of authentic transport vesicles ([@bib54]; [@bib44]). After treatment with nocodazole and with or without rapamycin, the cells were perforated and DOPC liposomes labeled with Rhod-PE were added. Without rapamycin, the ALPS-containing construct and the small liposomes colocalized at Golgi mini stacks as identified by GM130 antibody ([Figure 3B](#fig3){ref-type="fig"}). With rapamycin, colocalization between the ALPS-containing construct and the liposomes remained, but the liposomes and the ALPS construct overlapped better with mitochondria than with the Golgi mini stacks ([Figure 3C](#fig3){ref-type="fig"} and [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}). Furthermore, only small liposomes but not large liposomes bound to mitochondria through the ALPS-containing construct ([Figure 3---figure supplement 2](#fig3s2){ref-type="fig"}). Thus, mitochondria-anchored ALPS efficiently competes with the Golgi to capture small liposomes.10.7554/eLife.16988.007Figure 3.Mitochondria-anchored GMAP-210 ALPS competes with Golgi mini stacks for the capture of small liposomes.(**A**) Scheme of the constructs and principle of the experiment. Cells expressing ALPS-ACC1-GFP-FKBP and Mito-FRB were treated with nocodazole to disperse the Golgi apparatus into mini stacks. Thereafter, the cells were either treated with rapamycin or not, perforated, and incubated with small DOPC liposomes (extrusion: 30 nm). (**B**) In the absence rapamycin, small liposomes (extrusion 30 nm) colocalize with ALPS-ACC1-GFP-FKBP and with the Golgi mini stacks (as stained by anti GM130 antibody). (**C**) In the presence rapamycin, the small liposomes and ALPS-ACC1-GFP-FKBP colocalize in many regions that are negative for GM130. All images were acquired with a confocal microscope and were analyzed using Volocity software. These experiments were repeated three times. Data show representative images. Scale bars: 10 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.16988.007](10.7554/eLife.16988.007)10.7554/eLife.16988.008Figure 3---figure supplement 1.Competition between mitochondria-anchored GMAP-210 ALPS and Golgi mini stacks for liposome capture.Cells were treated with nocodazole to disperse the Golgi apparatus into mini stacks and then with rapamycin to attach ALPS-ACC1-GFP-FKBP to mitochondria through Mito-FRB. Thereafter, the cells were perforated and incubated with small DOPC liposomes (extrusion: 30 nm). The mitochondria were visualized with MitoTracker. Images were acquired with a confocal microscope. Note that cell perforation causes the mitochondria network to break into small circular elements, around which ALPS-ACC1-GFP-FKBP and small DOPC liposomes were found. These experiments were repeated three times. Data show representative images. Scale bars: 10 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.16988.008](10.7554/eLife.16988.008)10.7554/eLife.16988.009Figure 3---figure supplement 2.Mitochondria-anchored ALPS of GMAP-210 captures small but not large liposomes.Cells were treated with nocodazole to disperse the Golgi apparatus into mini stacks and with rapamycin to attach ALPS-ACC1-GFP-FKBP to mitochondria through Mito-FRB. Thereafter, the cells were perforated and incubated with small (extrusion: 30 nm) or large (extrusion: 200 nm) DOPC liposomes. After several washes, images were acquired with a confocal microscope and were analyzed using Volocity software. Note that only small liposomes are captured by the ALPS construct. These experiments were repeated three times. Data show representative images. Scare bars: 10 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.16988.009](10.7554/eLife.16988.009)

Selective *cis* Golgi targeting of the ALPS motif of GMAP-210 {#s2-3}
-------------------------------------------------------------

Having determined the contribution of GMAP-210 to the exceptional liposome tethering activity of the Golgi, we next addressed the mechanism of recognition of authentic transport vesicles. Recent works showed that GMAP-210 selectively captures vesicles of the early secretory pathway, thereby contributing to efficient forward and backward traffic between the ER and the Golgi ([@bib54]; [@bib43]). Furthermore, deletion of the ALPS motif abolishes this activity ([@bib44]). We wished to determine whether the ALPS motif of GMAP-210 recognizes transport vesicles through the same mechanism as that observed in vitro, that is, *via* its amphipathic properties ([@bib17]; [@bib41]). Given the high selectivity of GMAP-210 for vesicles of the early secretory pathway ([@bib54]; [@bib43]), an alternative possibility was that the ALPS motif engages in stereospecific interactions with a protein or a lipid.

We designed various fluorescent constructs derived from the N-terminal region of GMAP-210 ([Figure 4A](#fig4){ref-type="fig"}). ALPS-GCC-GFP (or mCherry) contained the N-terminal ALPS motif \[1--38\] and one quarter of the downstream coiled-coil region \[39--375\] (GCC) of GMAP-210, which was C-terminally fused to GFP (or mCherry). The other constructs were based on the same tripartite architecture (sensor/coiled-coil/fluorescent reporter), but contained a mutated ALPS motif and/or an artificial coiled-coil sequence (ACC1 or ACC2) to address the role of these regions in Golgi localization. The design of the artificial coiled-coil sequences ACC1 and ACC2 has been recently presented ([@bib25]). Note that none of the constructs contained the GRAB domain. Consequently, they could not target Golgi cisternae by interacting with Arf1-GTP ([@bib11]; [@bib22]) and should act as vesicle sensors rather than as vesicle tethers.10.7554/eLife.16988.010Figure 4.The ALPS motif of GMAP-210 targets *cis* Golgi vesicles.(**A**) Scheme of the constructs. The first construct corresponds to the N-terminal region of GMAP-210 (aa 1--375; ALPS = 1--38) fused to a C-ter fluorophore (GFP or mCherry). Alternatively, the ALPS motif of GMAP-210 was introduced upstream of an artificial coiled-coil (ACC1). (**B**) Subcellular localization of GCC- and ACC-based constructs by confocal fluorescence microscopy. Golgi localization was preserved by replacing the coiled-coil region of GMAP-210 (GCC) by an artificial coiled-coil (ACC1), but was abolished by deletion of the ALPS motif. Immunofluorescence of cells expressing ALPS-ACC1-GFP shows low colocalization with TGN46, intermediate overlap with GM130, and high colocalization with endogenous GMAP-210. All images were acquired with a confocal microscope and were analyzed using Volocity software. Scale bars: 10 µm, Z plane. (**C**) Immunogold EM of RPE1 cells expressing ALPS-ACC1-GFP. Scale bars: 10 µm (**B**) 100 nm (**C**). These experiments were repeated at least three times, except EM, which was repeated twice. Data show representative images.**DOI:** [http://dx.doi.org/10.7554/eLife.16988.010](10.7554/eLife.16988.010)10.7554/eLife.16988.011Figure 4---figure supplement 1.GMAP-210 depletion by siRNA does not affect the Golgi targeting of ALPS-containing probes.(**A**) RPE1 cells stably expressing ArfGAP1(R50K mutant)-GFP were transfected with siGMAP-210\#2 or control siRNA for 72 hr. (**B**) RPE1 cells were transfected with siGMAP-210\#2 or with control siRNA for 72 hr and then with ALPS-ACC1-GFP for 7 hr. In **A** and **B**, cells were then fixed, immunostained with antibodies against GMAP-210 and the cis-Golgi marker GalNT2, and visualized by confocal microscopy. Z plane, scale bar: 10 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.16988.011](10.7554/eLife.16988.011)10.7554/eLife.16988.012Figure 4---figure supplement 2.ALPS-ACC1-GFP increases the liposome capture properties of cells.RPE1 cells were transitory transfected with ALPS-ACC1-GFP for 7 hr. Thereafter, the cells were perforated and 250 µM DOPC liposomes (extrusion 0.03 µm) were added for 5 min at 30°C. After several washes, images were acquired with a wide-field microscope and processed with ImageJ. Perforated cells are indicated by an asterisk. Those that express ALPS-ACC1-GFP show much higher liposome signal than those that do not express the construct. Scale bar: 10 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.16988.012](10.7554/eLife.16988.012)

When coexpressed in RPE1 cells, ALPS-GCC-GFP and ALPS-ACC1-mCherry perfectly co-localized to a perinuclear region ([Figure 4B](#fig4){ref-type="fig"}). In contrast, ACC1-GFP, which lacks the ALPS motif, was entirely soluble ([Figure 4B](#fig4){ref-type="fig"}). Thus, the ALPS motif of GMAP-210 is not only necessary (as revealed by its deletion), but also sufficient (as revealed by coiled-coil permutation) for cellular localization. Double labeling with Golgi markers and with endogenous GMAP-210 indicated that ALPS-containing constructs display a *cis* (GM130) rather than a *trans* (TGN46) localization ([Figure 4B](#fig4){ref-type="fig"}). However, colocalization with GM130 was partial, in agreement with the observation that GMAP-210 is enriched in *cis* Golgi regions from which GM130 is absent ([@bib11]). Immunogold EM indicated that ALPS-ACC1-GFP labeled regions very rich in small (R ≈ 30 nm) vesicles ([Figure 4C](#fig4){ref-type="fig"}).

Next, we assessed the effect of reducing GMAP-210 levels on the targeting of ALPS-containing constructs to the Golgi. In contrast to what we observed for the capture of liposomes ([Figure 2](#fig2){ref-type="fig"}), cells treated with siRNA against GMAP-210 kept robust Golgi staining of ALPS-ACC1-GFP as well as with catalytically inactive ArfGAP1-GFP, another ALPS-containing protein ([@bib50]) ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). This result can be interpreted in light of previous EM observations. GMAP-210 depletion causes small vesicles to accumulate at the Golgi at the expense of the normal cisternae organization ([@bib44]), an effect that probably results from a reduction in speed of Golgi assembly through homotypic vesicle fusion. Therefore, whereas GMAP-210 depletion reduces the possibility of small liposomes to interact with the Golgi, it still preserves the ability of ALPS-motif containing proteins to target this organelle *via* contact with authentic transport vesicles.

As an alternative strategy to connect the liposome capture properties of the Golgi and the behavior of the ALPS-ACC1-GFP probe, we added small liposomes on perforated cells overexpressing ALPS-ACC1-GFP. As shown in [Figure 4---figure supplement 2](#fig4s2){ref-type="fig"}, cells expressing ALPS-ACC1-GFP showed higher levels of liposome capture than neighboring cells that do not express this construct. Together with the effect of GMAP-210 depletion ([Figure 2](#fig2){ref-type="fig"}), this observation further underlines the contribution of the ALPS motif of GMAP-210 to the ability of the Golgi to capture small liposomes.

The ALPS motif of GMAP-210 does not engage stereospecific interactions {#s2-4}
----------------------------------------------------------------------

To test whether the fine Golgi localization conferred by GMAP-210 ALPS motif relied on stereospecific interactions, we inverted the ALPS sequence (i.e. read it from the carboxy terminus to the amino terminus; [Figure 5A](#fig5){ref-type="fig"}). A helical plot shows that this inversion keeps intact the physicochemical features of the ALPS motif including its amphipatic character and, therefore, should not affect its membrane adsorption properties ([Figure 5B](#fig5){ref-type="fig"}). In contrast, the inversion corresponded to 30 mutations over 38 positions ([Figure 5A](#fig5){ref-type="fig"}) and should strongly perturb any stereospecific interaction with a particular protein or lipid. We previously showed that inverting the ALPS sequence does not compromise the Golgi localization of GMAP-210-based probes in *S cerevisiae* ([@bib41]). However, the yeast homolog of GMAP-210 (Rud3p; \[[@bib22]\]) does not contain an ALPS motif and we considered the possibility that GMAP-210 had acquired additional interactions in its natural context.10.7554/eLife.16988.013Figure 5.Selective targeting of the ALPS motif of GMAP-210 to *cis* Golgi vesicles without stereospecific interactions.(**A**, **B**) Sequence comparison of the ALPS motif of GMAP-210 and the corresponding inverted motif (invALPS). The two sequences have low identity (≈ 25%; **A**), but helical wheel-representations (**B**) show that they display the same amphipathic character. Helical representations were made with Heliquest ([@bib20]).(**C**) A coiled-coil construct harboring an inverted ALPS motif (invALPS-ACC2-GFP) displays the same subcellular localization as a construct harboring the original ALPS motif (ALPS-ACC1-mCherry). (**D**) Pearson coefficient between the green and red channels for the constructs shown in (**C**) as well as for other combinations of constructs or endogenous proteins. 30 cells were examined from 3 independent experiments. The vertical black bars show the mean ± SD. All images were acquired with a confocal microscope and were analyzed using Volocity software. Scale bars: 10 µm, Z plane.**DOI:** [http://dx.doi.org/10.7554/eLife.16988.013](10.7554/eLife.16988.013)

[Figure 5C](#fig5){ref-type="fig"} shows a cell co-expressing a green construct containing the inverted ALPS motif (invALPS-ACC2-GFP) and a red construct containing the normal ALPS motif (ALPS-ACC1-mCherry). The two constructs had different coiled-coil regions to prevent the formation of heterodimers ([@bib25]). Remarkably, ALPS-ACC1-mCherry and invALPS-ACC2-GFP showed exactly the same Golgi localization despite the fact that these constructs were different along their entire sequence. The Pearson's coefficient between the green and red channels was not only very high (0.75), but also similar to that observed when two coiled-coil constructs harbored an intact ALPS motif ([Figure 5D](#fig5){ref-type="fig"}). These results demonstrate that the strict order of amino acids in the ALPS sequence is not critical for its fine targeting to the Golgi, making the involvement of stereospecific interactions unlikely.

The ALPS motif of GMAP-210 interacts with Golgi vesicles as an amphipathic helix {#s2-5}
--------------------------------------------------------------------------------

Having ruled out a stereospecific mode of membrane recognition, we wished to test the alternative hypothesis, namely that the ALPS motif of GMAP-210 targets Golgi vesicles by merely adsorbing to their surface as an amphipathic helix. For this, we used a different mutagenesis strategy. Instead of introducing a large number of mutations while keeping the physicochemical properties of the sequence intact, we introduced a minimal number of mutations to disrupt the amphipathic character of the sequence. This included placing a single negatively charged residue in the hydrophobic face (L12D), inserting two alanines to break the regular spacing of polar and non-polar residues (InsAA20), and replacing a glycine by a proline to create a bend (G11P). In all cases, the *cis*-Golgi localization of the mutated constructs dropped in favor of the cytosolic fraction ([Figure 6A,C](#fig6){ref-type="fig"} and [Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}).10.7554/eLife.16988.014Figure 6.The ALPS motif of GMAP-210 interacts with Golgi vesicles as an amphipathic helix.(**A**) Effect of mutations disrupting the amphipathic character of the ALPS motif of GMAP-210. For each mutant, a helical plot made with Heliquest ([@bib20]) is shown. Mutation L12D introduces a negative charge in the hydrophobic face. Ins20AA corresponds to 2 alanines inserted in the middle of the ALPS sequence. G11P should rigidify the sequence. (**B**) Effect of gradual truncation of the ALPS sequence. All mutants shown in (**A**) and (**B**) were derived from ALPS-ACC1-GFP. (**C**) Quantification. For both (**A**) and (**B**), ten cells were analyzed for each mutant. Once the background was subtracted, two ROI with same area were applied in the Golgi and in the cytosol. The average fluorescence was determined in each ROI and the Golgi/cytosol ratio was then calculated. All images were acquired with a confocal microscope and were analyzed using Volocity software. Scale bars: 10 µm, Z projections. Scale bars: 10 µm. The figure shows one experiment where all constructed were transfected in parallel and ten cells were analyzed for each condition. The horizontal bars show the means. Other experiments were performed with subgroups of mutants and gave similar results.**DOI:** [http://dx.doi.org/10.7554/eLife.16988.014](10.7554/eLife.16988.014)10.7554/eLife.16988.015Figure 6---figure supplement 1.Effects of point mutations on the Golgi localization of the ALPS motif of GMAP-210.This figure shows different images of the subcellular localization of some mutants described in [Figure 6](#fig6){ref-type="fig"}. The mutants G11P and \[1--6/29--38\] have a clear Golgi localization. However, their cytosolic fluorescent signal is much higher than that of wild-type ALPS-ACC1-GFP, implying a lower Golgi/cytosol ratio (see [Figure 6C](#fig6){ref-type="fig"}). Scale bar: 10 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.16988.015](10.7554/eLife.16988.015)

The ALPS motif of GMAP-210 displays a monotonous sequence made of similar helical turns (typically \[LGx\] or \[LGxx\]; [Figure 5A](#fig5){ref-type="fig"}). We reasoned that if all these turns insert at the surface of Golgi vesicles, their contribution to the overall binding energy should be similar. We thus designed a series of truncated forms in which two helical turns were successively deleted. All truncated constructs showed strong impairment in Golgi targeting suggesting that the full ALPS sequence contributes to membrane binding ([Figure 6B,C](#fig6){ref-type="fig"} and [Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}).

In conclusion, the mutagenesis analysis shown in [Figures 5](#fig5){ref-type="fig"} and [6](#fig6){ref-type="fig"} suggests that, despite being very selective for Golgi vesicles, the ALPS motif of GMAP-210 does not target them through stereospecific interactions, but simply through its amphipathic properties.

The sparse distribution of hydrophobic residues in ALPS enables selective Golgi targeting {#s2-6}
-----------------------------------------------------------------------------------------

ALPS motifs are defined by the abundance of uncharged residues (S, T, G) in their polar face and contain bulky hydrophobic residues (F, L, W) in their non-polar face ([@bib5]; [@bib37]; [@bib17]). As compared to ALPS, the most contrasting amphipathic α-helix is α-synuclein, which contains charged residues (K, E) in its polar face and small hydrophobic residues (V, T) in its non-polar face. We previously showed that the opposite traits of ALPS and α-synuclein correlate with their different subcellular localization ([@bib41]). However, the exquisite subcellular localization of the ALPS motif of GMAP-210 remains puzzling when compared to that of other amphipathic α-helices. The N-terminal helices of Arf1 and Sar1, two small G proteins that drive the assembly of protein coats on the ER and the Golgi, are also poor in charged residues ([@bib16]). Yet, these small G proteins display a wider cellular distribution than the ALPS motif of GMAP-210. Moreover, in biochemical assays, ALPS-motif containing proteins are much more sensitive to membrane curvature than Arf1 ([@bib6]; [@bib18]; [@bib1]). Therefore, we surmised that another feature of the ALPS motif might contribute to its selective membrane adsorption properties.

Sequence comparison shows that the distribution of hydrophobic residues in the ALPS motif of GMAP-210 strongly differs from that of Arf1 and Sar1 ([Figure 7A](#fig7){ref-type="fig"}). In ALPS, most helical turns (9 out of 11) contain a single hydrophobic residue (e.g. [L]{.ul}xxx[L]{.ul}xxx[L]{.ul}); in Arf1 and Sar1, most helical turns contain two adjacent hydrophobic residues (e.g. [IF]{.ul}xx[LF]{.ul}xx[LF]{.ul} in Arf1). To determine whether the sparse distribution of hydrophobic residues in ALPS plays a role in membrane selectivity, we created a condensed ALPS motif (condALPS) by deleting polar residues such as to create hydrophobic pairs akin to what is found in Arf or Sar ([Figure 7A](#fig7){ref-type="fig"}). The resulting amphipathic helix was shortened but retained all hydrophobic residues of the wild-type form.10.7554/eLife.16988.016Figure 7.The sparse distribution of hydrophobic residue in ALPS determines its selective cellular targeting and its sensitivity to membrane curvature.(**A**) Sequence comparison between the ALPS motif of GMAP-210 and the amphipathic helices of Arf1 and Sar1. Hydrophobic residues are shown in bold. In ALPS, most hydrophobic residues are sparse. In Arf1 and Sar, most hydrophobic residues are paired. By removing polar residues between sparse hydrophobic residues, the ALPS sequence was condensed (condALPS) to create hydrophobic pairs. (**B**) Localization of ALPS-ACC1-GFP, condALPS-ACC1-GFP, and Sar1-ACC1-GFP in RPE1 cells. Lipid droplets were revealed by lipidTox staining (red). Imaged were acquired from living cells using a spinning disk microscope. Z planes, scale bar: 10 µm. (**C**) Effect of adding hydrophobic residues in the ALPS 1--38 sequence or in the 8--30 truncated mutant. All mutants derived from the ALPS-ACC1-GFP construct. (**D**) Sensitivity of ALPS and condALPS peptides to membrane curvature. The peptides (1 µM) were incubated with liposomes (lipids 0.5 mM) of defined size. Tryptophan fluorescence was measured between 300 to 450 nm. The right plot shows the relative fluorescence at 340 nm as a function of liposome radius, setting the fluorescence in solution at 1. Error bars: SEM from four independent experiments. Scale bars: 10 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.16988.016](10.7554/eLife.16988.016)10.7554/eLife.16988.017Figure 7---figure supplement 1.Subcellular localization of ALPS-ACC1-GFP, condALPS-ACC1-GFP, and Sar1-ACC1-GFP in RPE1 and U2OS cells.In RPE1 cells, condALPS-ACC1-GFP and Sar1-ACC1-GFP intensively labeled lipid droplets and to a lesser extent the ER and the nuclear envelope. In U2OS cells, the ER localization of condALPS-ACC1-GFP and Sar1-ACC1-GFP is more obvious given the reticular pattern of the ER in these cells. Imaged were acquired from living cells using a spinning disk microscope. Z planes, scale bar: 10 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.16988.017](10.7554/eLife.16988.017)10.7554/eLife.16988.018Figure 7---figure supplement 2.The sparse distribution of hydrophobic residue in ALPS determines its selective cellular targeting.This figure shows the subcellular localization of the same constructs as shown in [Figure 7](#fig7){ref-type="fig"} but in comparison with the cis Golgi marker GM130. Whereas wild-type ALPS displays Golgi localization, mutants with hydrophobic pairs bind to other organelles besides the Golgi (e.g. nuclear envelope, ER network, lipid droplets). Scale bar: 10 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.16988.018](10.7554/eLife.16988.018)

[Figure 7B](#fig7){ref-type="fig"} compares the cellular localization of coiled-coil constructs (ACC1-GFP) harboring an intact ALPS motif, a condensed ALPS motif, or the Sar1 amphipathic helix (for other examples see also [Figure 7---figure supplements 1](#fig7s1){ref-type="fig"} and [2](#fig7s2){ref-type="fig"}). Whereas, the former was concentrated in the *cis* Golgi area, the constructs harboring condALPS or Sar1AH decorated not only the Golgi but also the nuclear envelope, the ER network and lipid droplets. Thus, amphipathic helices containing hydrophobic doublets seem more promiscuous than those containing sparse hydrophobic residues. To confirm this finding, we added additional hydrophobic residues in the ALPS motif of GMAP-210 or in shorter constructs ([Figure 7C](#fig7){ref-type="fig"} and [Figure 7---figure supplement 2](#fig7s2){ref-type="fig"}). Again, we observed that the mutated constructs localized to various organelles including the Golgi, the ER and lipid droplets. We also noticed that the only truncated mutant of ALPS that showed significant Golgi localization (\[1--6/29--38\]) was less typical in sequence as it contained the only helical turn with two adjacent hydrophobic residues (~4~WL~5~; [Figure 6B,C](#fig6){ref-type="fig"}). This observation further confirms the importance of the distribution of hydrophobic residues for tuning the avidity and selectivity of amphipathic helices for lipid membranes.

A \'condensed\' ALPS mutant binds lipid membranes regardless of curvature in vitro {#s2-7}
----------------------------------------------------------------------------------

Next, we wished to compare the biochemical properties of coiled-coil constructs harboring condALPS or ALPS. All constructs containing condALPS were poorly soluble when expressed in bacteria, thereby preventing an analysis similar to that shown in [Figure 1F](#fig1){ref-type="fig"}. To circumvent this limitation, we used two synthetic peptides corresponding to the ALPS and condALPS sequences, respectively, and followed their partitioning to model membranes by monitoring the blue shift and increase in tryptophan fluorescence that occur upon membrane binding ([@bib17]). In the case of wild-type ALPS, membrane binding to liposomes was very low, except for the smallest liposomes obtained by sonication ([Figure 7D](#fig7){ref-type="fig"}). In contrast, condALPS partitioned readily to all liposomes regardless of their size ([Figure 7D](#fig7){ref-type="fig"}). Thus, the sparse distribution of hydrophobic residues in ALPS motif contributes to its sharp sensitivity to membrane curvature.

Lipid-packing defects are maximal in vesicles with an ER/*cis* Golgi-like composition {#s2-8}
-------------------------------------------------------------------------------------

The mechanism by which amphipathic helices adsorb on the surface of lipid membranes is difficult to experimentally address ([@bib26]). In the case of ALPS motifs, molecular dynamics (MD) simulations suggest a plausible sequence whereby bulky hydrophobic residues randomly insert into lipid packing defects (i.e. voids) present on the membrane interfacial region ([@bib48]; [@bib51]). When the density of these defects is high enough, multiple hydrophobic insertions occur, thereby favoring ALPS folding at the membrane surface. Importantly, a topographic analysis indicates that the abundance of lipid packing defects that are large enough to accommodate bulky hydrophobic residues sharply increases with both membrane curvature and with lipid unsaturation in agreement with the adsorption properties of ALPS motifs ([@bib50]). However, these simulations were performed with simple PC membranes.

We wished to determine if lipid-packing defects of the same size are present in vesicles travelling between the ER and *cis* Golgi (i.e. formed by the COPI or COPII coats). For this, we built coarse-grained models of bilayers of different shape with a composition approaching that of the ER/*cis* Golgi interface ([@bib49]) and including COPI vesicles for which a comprehensive lipid analysis exists ([@bib9]) ([Figure 8A](#fig8){ref-type="fig"}). The models consisted in PC (60 mol%) and phosphatidylethanolamine (PE; 30 mol%) as the main glycerophospholipid lipids as well as 10 mol% cholesterol ([Figure 8B](#fig8){ref-type="fig"}). The acyl chain distribution of PC and PE matched that of COPI vesicles with a minor proportion of saturated species (C16:0-C16:0), an intermediate level of monounsaturated species (C18:1-C18:1), and a majority of mixed saturated-monounsaturated species (C16:0-C18:1) ([Figure 8B](#fig8){ref-type="fig"}).10.7554/eLife.16988.019Figure 8.Distribution of lipid packing defects in model *cis* Golgi membranes.(**A**) Typical coarse grained models of lipid bilayers with a lipid composition similar to that of COPI vesicles ([@bib9]) and with a flat, tubular or spherical geometry. (**B**) Lipid composition of the bilayers. (**C**) Lipid packing defect distribution. For comparison, the results from simulations with flat POPC or spherical DOPC membranes ([@bib50]) are also shown. The inset shows the ratio between the number of defects in the vesicle or in the tube as compared to the flat membrane.**DOI:** [http://dx.doi.org/10.7554/eLife.16988.019](10.7554/eLife.16988.019)

By scanning the surface of these bilayers, we determined the distribution of lipid packing defects. As observed previously ([@bib14]; [@bib48]; [@bib50]), the abundance of lipid packing defects falls off with their area according to an exponential decay $e^{( - A/Ac)}$, where *A* is the area of the defect and *Ac* is an area constant ([Figure 8C](#fig8){ref-type="fig"}). Thus, large defects are always less abundant than smaller ones and a high *Ac* value indicates a bilayer rich in lipid packing defects. The analysis shows that *cis* Golgi bilayers fall between POPC and DOPC membranes in term of distribution of lipid packing defects and that membrane curvature increases the probability of having large defects ([Figure 8C](#fig8){ref-type="fig"}). To quantify this increase, we calculated the relative abundance of lipid packing defects between curved and flat Golgi bilayers ([Figure 8C](#fig8){ref-type="fig"}, inset). Lipid packing defects large enough to accommodate ALPS bulky hydrophobic residues (\>20 Å^2^; \[[@bib51]\]) were *ca*. 2--3 times more abundant in tubules and 3--5 times more abundant in vesicles as compared to flat bilayers. We concluded that the ALPS motif is best adapted to sense the surface of the most highly curved membranes of the early secretory pathway, notably vesicles formed by the COPI and COPII coats and whose radius ranges between 30 and 40 nm ([@bib34]; [@bib3]).

Discussion {#s3}
==========

The Kobayashi and Pagano experiment was remarkable in its simplicity -- mixing liposomes with perforated cells -- and in its outcomes: the Golgi has an exceptional liposome tethering capacity, which is accompanied by size filtration ([@bib30]). By connecting these pioneering observations with the molecular and cellular properties of the golgin GMAP-210 ([@bib18]; [@bib54]; [@bib44]; [@bib43]), our study suggests that the ALPS motif of GMAP-210 acts a filter at the *cis* entrance of the Golgi to select transport vesicles according to their size and bulk lipid composition.

The ALPS motif of GMAP-210 should be one of the first binding sites that a vesicle entering the golgin matrix should encounter and its sharp preference for small liposomes (R \< 40 nm) suggested a mechanism for vesicle capture ([@bib17], [@bib18]). The present study with perforated cells further underlines the relevance of this mechanism in a cellular context and also gives insights about its efficiency. We estimate that the Golgi can capture hundreds of small DOPC liposomes (R ≈ 30 nm). This range compares reasonably well with the vesicle density at the Golgi as determined by electron tomography: Ladinsky et al. reported *ca.* 400 vesicles in a tomogram corresponding to 5% of the Golgi area, whereas Marsh et al. reported \>2000 vesicles in a larger region ([@bib32]; [@bib36]). Other clues for the efficiency of this mechanism are the massive accumulation of small (R ≈ 30 nm) vesicles in the form of tight clusters when GMAP-210 is overexpressed in yeast or in mammalian cells ([@bib40]; [@bib41]) as well as the displacement of the liposome capture properties when cells express GMAP-210 at the surface of mitochondria ([Figure 3](#fig3){ref-type="fig"}). However, GMAP-210 might not be the only golgin accounting for the ability of the Golgi to capture liposomes. Among the various golgins present in mammalian cells ([@bib21]), we identified another ALPS motif in giantin ([@bib17]). This motif is located within the coiled coil region and therefore might not be involved in the initial capture of vesicles but rather in their movement within the golgin matrix. In the future, combining genetic tools to modify the repertoire of vesicle tethers and liposome-binding experiments on perforated cells should facilitate the analysis of the various modes of vesicle capture by the Golgi and other organelles ([@bib24]; [@bib39]; [@bib31]).

Mitochondria de-routing experiments indicate that GMAP-210 is selective for vesicles of the early secretory pathway ([@bib54]). Furthermore, functional and structural dissection of GMAP-210 indicates that its ALPS motif has an essential role in vesicle capture ([@bib44]). Our study suggests that the vesicle selectivity of GMAP-210 does not arise from stereospecific interactions between the ALPS motif and particular protein or lipid determinants, but from the unusual amphipathic properties of this motif. One striking observation is that the targeting of GMAP-210 ALPS to the Golgi is resistant to sequence inversion but is very sensitive to mutations that modify its amphipathic character ([Figures 5](#fig5){ref-type="fig"}, [6](#fig6){ref-type="fig"}). Notably, mutations that disrupt the helix amphipathy cause ALPS dissociation, whereas mutations that reinforce the hydrophobic face promote recognition of other organelles besides the Golgi. Thus, the physicochemical properties of the ALPS motif of GMAP-210 seem exquisitely tuned for selective adsorption on the surface of small vesicles of the early secretory pathway. Besides the chemistry of ALPS per se, the dimeric architecture of GMAP-210 also contributes to membrane curvature recognition ([@bib15]).

ALPS motifs differ from most membrane-adsorbing helices by the lack of charged residues and the abundance of small neutral residues in the polar face ([@bib17]; [@bib16]; [@bib41]). The present study identifies the distribution of hydrophobic residues as a second parameter accounting for the hypersensitivity of ALPS motifs to membrane curvature ([Figure 6](#fig6){ref-type="fig"}). In ALPS, most helical turns contain a single hydrophobic (H) residue (HxxxHxxH...) ([@bib23]). In Arf1 and Arf1-like proteins, the N-terminal amphipathic helix contains two hydrophobic residues per turn (HHxxHHx...). Condensing the ALPS sequence in order to pair all single hydrophobic residues makes the helix no longer sensitive to membrane curvature and eliminates its restrictive Golgi distribution ([Figure 6](#fig6){ref-type="fig"}). We suggest that the presence of a single hydrophobic residue per turn prevents each helical turn from being too tightly bound. Since this feature is repeated many times, this amplifies the helix sensitivity to the lipid packing properties of the membrane interface ([@bib2]). In conclusion, the ALPS motif of GMAP-210 is optimized to select small vesicles, whereas Arf1 and Arf-like proteins are more permissive to membrane curvature, which enables them to initiate, by a GTP switch, the recruitment of various effectors (coats, tethers, lipid-modifying enzymes, lipid transporters) on membranes of diverse shape ([@bib12]).

The membrane of the ER and the *cis* Golgi differ from that of other organelles in their bulk features, including low sterol, low electrostatics and high level of unsaturation ([@bib49]; [@bib4]). Molecular dynamics simulations suggest that this latter trait, together with the high curvature of transport vesicles (R = 30--40 nm, for both COPI and COPII vesicles; \[[@bib34]; [@bib3]\]) leads to a high level of lipid packing defects, which enable the adsorption of ALPS motifs ([Figure 8](#fig8){ref-type="fig"} and \[[@bib51]\]). The observation that excess phospholipid saturation prevents the correct partitioning of ArfGAP1 at the Golgi supports this model ([@bib50]). In addition, COPI vesicles, which bud from the *cis* Golgi, are rich in unsaturated PC and poor in cholesterol and saturated lipids ([@bib9]). Therefore, we propose that GMAP-210 recognizes vesicles that shuttle cargoes between the ER and the *cis* Golgi because their membrane combines the highest level of unsaturation with the highest level of curvature. In contrast, small vesicles on the *trans* side of the Golgi are probably ignored by GMAP-210 because their physical features, notably a more ordered bilayer structure ([@bib29]), are not adapted to the ALPS motif.

In conclusion, GMAP-210 seems to act as a general filter at the *cis* side of the Golgi to select vesicles solely on the basis of their small size and loose lipid packing structure. This mechanism might be sufficient to sort pre Golgi *versus* post Golgi vesicles, thereby maintaining the polarity of this organelle, because changes in lipid composition along the secretory pathway (e.g. sterol accumulation and sphingolipid synthesis) occur mostly at the *trans* side ([@bib49]; [@bib4]). In contrast, GMAP-210 is probably not able to distinguish subclasses of vesicles at the ER/cis Golgi interface. GMAP-210 controls both anterograde and retrograde flows between the ER and the cis Golgi ([@bib40]; [@bib43]) and, when artificially anchored on the mitochondria, captures ER-derived vesicles as well as those that contain Golgi resident enzymes ([@bib54]). This lack of discrimination might be advantageous for building a new *cis* Golgi cisternae by merging these different vesicles. The only transport intermediates at the ER/Golgi interface that should not be captured by GMAP-210 are large carriers, which transport proteins too big to be packaged into classical vesicles ([@bib33]). In this respect, it is interesting to note that deletion of GMAP-210 in mouse leads to defects in the secretion of a relatively small matrix protein, perlecan, but not of large collagens ([@bib47]). GMAP-210 is also reported to function in the cilium formation ([@bib19]). A plausible hypothesis is that GMAP-210 diverts vesicles with a special level of lipid unsaturation from the Golgi. As such, GMAP-210 could help building an organelle that, despite being continuous with the plasma membrane, displays a very different lipid composition ([@bib52]).

Materials and methods {#s4}
=====================

Constructs {#s4-1}
----------

ACC1 and ACC2 are artificial coiled-coils. Their design, their sequences and the corresponding synthetic genes (Eurofins, Luxembourg) have been previously described ([@bib25]). The ALPS motif of GMAP-210 (aa 1--38) was cloned in a pEGFP-N1 vector (Clonetech, Japan) upstream of ACC1, thereby giving the ALPS-ACC1-GFP construct. The cloning restriction site was BamHI. The ALPS point mutants (L12D, G11P, Ins20AA), the ALPS truncated mutants (\[1--14\], \[8--38\], \[15--38\], \[1/6--29/38\], \[22--38\]), as well as condensed ALPS were prepared from ALPS-ACC1-GFP using the QuikChange Lightning kit (Agilent Technologies, CA., USA) according to the manufacturer's instructions. InvALPS was prepared from a synthetic gene including the ACC2 sequence. Sar1-ACC1-GFP was prepared by inserting the amphipathic helix of Sar1 in the ACC1-GFP vector using directed mutagenesis ([@bib15]).

For ALPS-ACC1-GFP-FKBP, we inserted ALPS-ACC1-GFP in a ProteoTuner vector (Clonetech, Japan) that contains a modified FKBP domain (degradation domain). This domain was mutated back to the wild-type form by introducing the following mutations: G31E, V36F, G71Q and E105K. Mito-FRB was a gift from M. Lowe ([@bib44]).

Cell culture, protein expression and antibodies {#s4-2}
-----------------------------------------------

hTERT-RPE1 cells (purchased from ATCC, VA, USA) were cultured in DMEM/F12 medium with glutaMAX (Gibco, Thermo Fisher Scientific, MA, USA) containing 10% serum, 1% antibiotics (Zell Shield, Minerva Biolabs, Germany) and were incubated in a 5% CO~2~ humidified atmosphere at 37°C. hTERT-RPE1 cells stably expressing Rab6-GFP (gift from B Goud) or ArfGAP1(R50K) ([@bib50]) were cultured in the same medium but supplemented with a geneticin (G418 500 µg/ml). In brief, cells were seeded on glass coverslips previously coated with fibronectin (4 μg/ml). Plasmids were transfected using Lipofectamine 2000 (Invitrogen, CA, USA). After 3--5 hrs, the cells were fixed with PFA 3% for 20 min at room temperature. Golgi staining was performed using mouse monoclonal antibody against GM130 (ref 610822-BD, Transduction laboratories, KY, USA) and sheep polyclonal antibody against TGN46 (ref AHP500G-AbD, Serotec, Bio-Rad Laboratories, CA, USA). Antibody against endogenous GMAP-210 was provided by Michel Bornens (Institut Curie Paris) ([@bib27]). Purified mouse anti-GMAP-210 was from BD transduction laboratories (ref 611712). Coverslips were mounted in Mowiol and observed using a confocal microscope (Leica-SP5 or Zeiss LSM-780). Images were analyzed by volocity software or Image J.

For lipid droplets staining, live cells were incubated for 10 min with HCS lipidTOXred neutral lipid stains (Invitrogen). Experiments with live cells were performed using a spinning disk confocal microscope (UltraVIEW - Perkin Elmer, MA, USA).

Cell perforation and incubation with liposomes {#s4-3}
----------------------------------------------

We followed the method previously described ([@bib45]; [@bib30]). hTERT-RPE1 cells or RPE1-Rab6GFP cells were seeded on glass coverslips (diameter 35 mm) previously coated with fibronectin (10 μg/ml) until confluence. Cells on coverslips were washed in DMEM/F12 medium without red phenol (Gibco Thermo Fisher Scientific, MA, USA) and the excess moisture was removed by touching the edge of the coverslip with a filter paper. A 25 mm diameter filter (HATF, 0.45 µm pore size, Millipore) was soaked in perforation buffer (25 mM HEPES-KOH pH 7.2, 115 mM KCl, 2.5 mM MgCl~2~), blotted against filter paper, and placed on top of the coverslip. After 1 min at room temperature, the filter was slowly peeled from the cells. The coverslip was placed in a support for life microscopy, and 400 µl of liposomes solution was immediately added. After 5 min of incubation at 30°C, cells were washed several times with DMEM/F12 medium without red phenol (Gibco) and cells were observed in a wide-field microscope (Olympus IX83). The Golgi area was determined by the Rab6-GFP signal, and a corresponding mask was then applied to the red channel to determine the liposome fluorescence in the same area.

RNA interference {#s4-4}
----------------

Cells were transfected with 15 nM siRNA using Lipofectamine RNAiMAX (Invitrogen, CA, USA) for a 35 mm glass coverslip. ON-TARGET plus siRNAs targeting GMAP-210 were from Dharmacon (GE Healthcare, UK). They correspond to the siRNAs used by Roboti et al. ([@bib43]) and have the following sequences:

siGMAP-210\#1: GGAGAUAGCAUCAUCAGUA,ref:J-012684-05-0002

siGMAP-210\#2: CAAGAACAGUUGAAUGUAG, ref:J-012684-06-0002

non-targeting siRNA: UGGUUUACAUGUUGUGUGA, ref:D-001810-02-05

After 72 hr of transfection, cells were used for western blotting or for perforation. Expression of GMAP-210 was revealed with a purified mouse anti-GMAP-210 antibody (BD transduction laboratories, KY, USA) and the loading control was revealed with a monoclonal mouse anti-GFP antibody (Thermo Scientific, MA, USA).

Liposome-rerouting at mitochondria {#s4-5}
----------------------------------

Cells coexpressing ALPS-ACC1-GFP-FKBP and Mito-FRB were treated with 1 µM rapamycin (Sigma, MO, USA, ref R8781) for 1 hr to induce targeting of ALPS-ACC1-GFP-FKBP to the mitochondria outer membrane. When indicated, cells were also treated with nocodazole (2.5 µg/ml) to scatter the Golgi into mini stacks. This treatment was done 1 hr before and during rapamycin treatment. Thereafter, the cells were perforated and incubated with liposomes (250 µM lipids) as described above.

Peptides {#s4-6}
--------

The ALPS of GMAP-210 (aa 1--38) peptide and the condensed ALPS peptide were synthesized by ProteoGenix, France:

ALPS GMAP-210: CSS**WL**GG**L**GSG**L**GQS**L**GQ**V**GGS**L**AS**L**TGQ**I**SN**F**TKD**ML** (38 aa)

CondALPS: CSS**WL**GG**LL**GS**LV**GS**LL**T**IF**KD**ML** (24 aa)

Note that the first methionine was mutated into a cysteine and that the sequences contain one tryptophan residue, thereby allowing determination of peptide concentration by absorbance at 280 nm and liposome partitioning by fluorescence measurement.

Due to its high hydrophobicity, condALPS was only soluble in urea. Stock solutions of the two peptides (50 µM) were thus prepared in 4 M urea supplemented with 2 mM DTT.

Liposomes {#s4-7}
---------

All lipids were purchased from Avanti Polar Lipids (AL, USA). Lipids in chloroform were mixed in a pear-shape vial and dried in a rotary evaporator. The lipid film was hydrated at 2 to 10 mM lipids either in HK buffer (Hepes 50 mM, KAcetate 120 mM, pH 7,4) for biochemical experiments or in Hepes 25 mM, KCl 115 mM, MgCl~2~ 2.5 mM, pH 7,2 for the experiments with perforated cells. After five cycles of freezing and thawing, the liposomes were extruded sequentially through polycarbonate filters with pore diameters of 200, 100, 50 and 30 nm. Alternatively, small liposomes were obtained by sonication with a titanium tip sonicator (2 × 10 min in ice) and centrifuged for 20 min at 45,000 rpm to remove titanium debris. The liposome hydrodynamic radius (Rh) was measured by dynamic light scattering in a Dyna Pro instrument. Liposomes were stored at room temperature and used within one day.

Calibration of the liposome fluorescence signal at the Golgi {#s4-8}
------------------------------------------------------------

To convert the red fluorescence signal at the Golgi into a number of rhodamine-labeled liposomes, we imaged liposome suspensions in a Malassez cell (thickness 200 µm) using the same settings as that used for cell imaging (oil objective 60X, numerical aperture *NA *= 1.42). The mean fluorescence intensity per pixel increased linearly with liposome concentration (from 0 to 100 µM lipids) giving a conversion factor, *k*:

*k* ≈ 100 *FU.*µM^-1^

The mean fluorescence intensity per pixel at the Golgi after incubation with small DOPC liposomes is in the range of 2000 to 5000 *FU* ([Figure 1D](#fig1){ref-type="fig"}), thus corresponding to a lipid concentration *C* = 20 to 50 µM.

From our images, we estimated that the Golgi region occupies a volume in the range of:

*V* = 10 × 10 × 3 = 300 µm^3^ = 3 10^--13^ L.

In such a volume, a concentration of 20 to 50 µM corresponds to:

*C* × *V* × *N~av~* = 3.6 10^6^ to 9 10^6^ lipids, where *N~av~* is the Avogadro number.

The number of lipids in a small liposome (*R* = 30 nm) is ≈ $2\, \times \,\frac{4\pi R^{2}}{s}\, \approx \, 3\, 10^{4}$, where *s* is the surface of one lipid (*s* ≈ 0.7 nm^2^).

Thus, the Golgi has captured 120 to 300 small liposomes.

NBD and tryptophan fluorescence assay {#s4-9}
-------------------------------------

NBD experiments were performed at 37°C in a 4 × 4 mm cuvette (volume 240 µl) in a FP 8300 fluorimeter (Jasco, Japan). Excitation was set at 505 nm (bandwidth 2.5 nm). Emission was recorded from 520 to 650 nm (bandwidth 5 nm). The cuvette initially contained liposomes of defined size and composition (0.15 mM lipids) in HKM buffer (Hepes 50 mM, pH 7.4, Kacetate 120 mM, MgCl~2~ 1 mM, DTT 1 mM) and a blank spectrum was recorded. Thereafter, 0.125 µM NBD-labeled GMAP (1--375 fragment with the M1C mutation for NBD labeling \[[@bib41]\]) was added and another spectrum was recorded. The second spectrum was corrected for the blank.

For tryptophan fluorescence, excitation was set at 280 nm (bandwidth 5 nm) and emission was recorded from 300 to 450 nm (bandwidth 5 nm). The cuvette initially contained liposomes (DOPC/DOPE/Cholesterol 60/30/10 mol/mol; 0.5 mM lipids) of the indicated size in HKM buffer and a blank spectrum was recorded. Thereafter, 1 µM peptide (ALPS or condALPS) was added from 50X stock solutions in urea (4 M) and another spectrum was recorded and corrected for the blank.

MD simulations {#s4-10}
--------------

Simulations were done using the MARTINI force field of coarse-grained models of lipids as described previously ([@bib42]; [@bib50]) but using a composite lipid composition similar to that described by Brügger et al. on COPI vesicles ([@bib9]). The bilayer contained 60 mol% PC, 30 mol% PE and 10 mol% cholesterol. The acyl chain profile of PC and PE was 6 mol% C16:0-C16:0, 59 mol% 16:0-C18:1 and 35 mol% C18:1-C18:1. Note that the MARTINI coarse-grained model does not distinguish close lipid species such as C18:0-C18:1 and C16:0-C18:1. Therefore, these two lipid species, which are present in COPI vesicles, were simulated using the same coarse-grained model. The flat, tubular and spherical models of *cis* Golgi-like membranes were built from the corresponding DOPC structures ([@bib50]). In successive steps, the correct percentage of DOPC molecules was changed *via* molecular replacement into the new lipids (DPPE, POPE, DOPE, DPPC, POPC and cholesterol). After each molecular replacement, the system was minimized using a steepest descent algorithm. Next, the systems were subjected to MD runs of 900 ns (flat, tubule) and 150 ns (vesicle) in the NPT ensemble. Analyses were carried out on the last 600 ns (flat), 450 ns (tubule) and 100 ns (vesicle). All simulations details as well as analysis for lipid-packing defects are identical to those described previously ([@bib50]). Data for pure POPC and DOPC bilayers discussed in the text and shown in [Figure 8C](#fig8){ref-type="fig"} are also taken from our previous study ([@bib50]).
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In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your article \"A filter at the entrance of the Golgi that selects vesicles according to size and bulk lipid composition\" for consideration by *eLife*. Your article has been favorably evaluated by Randy Schekman (Senior editor) and three reviewers, one of whom, Suzanne Pfeffer, is a member of our Board of Reviewing Editors.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

This paper follows up on a striking observation from the Pagano lab, that liposomes, especially those of smaller radius, show preferential affinity for the Golgi when added to semi-intact cells. Here, the authors confirm this finding and show that a significant portion of Golgi affinity is due to the ALPS motif of the tethering protein, GMAP210. This study takes a phenomenological observation and converts it into an impactful, cell biological finding with an interesting molecular basis. The authors go on to show that an inverted amphipathic helix is sufficient and a condensed ALPS motif is less compartment-specific. In general the study is carried out to a high standard and the results will be of broad interest to the readers of *eLife*. The reviewers support presentation in *eLife* after the following issues have been adequately addressed.

1\) The title of the work is: \"A filter at the entrance of the Golgi that selects vesicles according to size and bulk lipid composition.\" The overall significance of the story would be greatly enhanced if the authors were to demonstrate the physiological significance of their findings in ALPS motif rescue experiments. This is of particular importance given reports suggesting that loss of GMAP210 can cause changes in cilia. The authors should use CRISPR to remove GMAP210 and then rescue with a version of GMAP210 that lacks the ALPS motif. This would allow them to determine if ER to Golgi traffic and intra-Golgi traffic are really dependent on the ALPS motif, and also to confirm the conclusion that the ALPS motif in GMAP-210 is the primary component responsible for liposome capture in permeabilized cells.

2\) An unexpected observation is that the ALPS motif alone is targeted to the early Golgi, as if vesicles are accumulating there for interaction. Is this true in GMAP-210 depleted cells? Is this also true for the ALPs motif from ArfGAP1? Please elaborate. Please provide evidence that this really is the Golgi vs. a peri-Golgi compartment.

3\) The mitochondrial tethering experiment data in [Figure 3](#fig3){ref-type="fig"} could be better of quality. In [Figure 3C](#fig3){ref-type="fig"} it is not clear what are Golgi fragments versus mitochondria. The same applies for [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}. Additional counterstains for mitochondria and Golgi would clarify the results. Also, some controls seem missing. There should be \[no rapamycin+nocodazole\], which is the better control for the \[rapamycin+nocodazole\] samples. [Figure 7](#fig7){ref-type="fig"} and [Figure 7---figure supplement 1](#fig7s1){ref-type="fig"} also need counter staining for the Golgi. It is not possible to easily discern the Golgi from other membrane compartments without the Golgi counter labelling.

4\) Results: \"GMAP-210 is responsible (*for a large portion*) of the ability of the Golgi\" (please modify). Are there other obvious candidate proteins that can explain the residual fluorescence detected over the Golgi in GMAP-210 depleted cells? Please discuss.

5\) [Figure 3C](#fig3){ref-type="fig"}. Why is nocodazole used? What happens if it is omitted? Also, given that the ALPS motif will capture endogenous small vesicles how can they be sure that the liposomes are not binding to these vesicles rather than directly to the ALPS motif?

6\) [Figure 6A](#fig6){ref-type="fig"}/C. It seems hard to reconcile the small effects seen by immunofluorescence with the large effects shown in the quantitation. This is in contrast with [Figure 6B](#fig6){ref-type="fig"} -- please explain.

10.7554/eLife.16988.021

Author response

*\[...\] The reviewers support presentation in eLife after the following issues have been adequately addressed.*

1\) The title of the work is: \"A filter at the entrance of the Golgi that selects vesicles according to size and bulk lipid composition.\" The overall significance of the story would be greatly enhanced if the authors were to demonstrate the physiological significance of their findings in ALPS motif rescue experiments. This is of particular importance given reports suggesting that loss of GMAP210 can cause changes in cilia. The authors should use CRISPR to remove GMAP210 and then rescue with a version of GMAP210 that lacks the ALPS motif. This would allow them to determine if ER to Golgi traffic and intra-Golgi traffic are really dependent on the ALPS motif, and also to confirm the conclusion that the ALPS motif in GMAP-210 is the primary component responsible for liposome capture in permeabilized cells.

The group of Martin Lowe has addressed this point in two papers that we cite several times in the text:

Roboti, P., Sato, K., & Lowe, M. (2015). The golgin GMAP-210 is required for efficient membrane trafficking in the early secretory pathway. Journal of Cell Science, 128(8), 1595--1606. <http://doi.org/10.1242/jcs.166710>

Sato, K., Roboti, P., Mironov, A. A., & Lowe, M. (2015). Coupling of vesicle tethering and Rab binding is required for in vivo functionality of the golgin GMAP-210. Molecular Biology of the Cell, 26(3), 537--553. <http://doi.org/10.1091/mbc.E14-10-1450>

In the first paper, the authors use siRNA against GMAP-210 to assess the involvement of GMAP-210 in several traffic steps between the ER and the Golgi (ER \> ERGIC \> Golgi and Golgi \> ER). Rescue experiments are presented in the second paper, which were conducted with various forms of GMAP-210, including ∆ALSP-GMAP-210.

These studies show that the ALPS motif is necessary for the vesicle tethering activity of GMAP-210 (a complete description of these deletion/rescue experiments is shown in Figure 10 of Sato et al). However, Lowe noticed: "We show here that GMAP-210--mediated tethering in cells is mediated exclusively by the N-terminal ALPS motif. On the face of it, this may appear surprising. Tethering is a specific process, with different golgins able to tether different types of vesicles (Wong and Munro, 2014), yet the ALPS motif binds to membrane lipids". Our study addresses this issue by showing the importance of curvature and lipid unsaturation for selective vesicle capture.

Of note, the efficiency of GMAP-210 silencing with siRNA is very high (typically, \> 95% in the case of Lowe; 85% in our case). Therefore, a CRISPR strategy is not mandatory at this point although this approach will be interesting to better address the physiological function of GMAP-210 in the future (as mentioned in the new final paragraph of the Discussion).

As for the physiological function of GMAP-210, two KO mouse have been presented:

Follit, J. A., Agustin, J. T. S., Xu, F., Jonassen, J. A., Samtani, R., Lo, C. W., & Pazour, G. J. (2008). The Golgin GMAP210/TRIP11 Anchors IFT20 to the Golgi Complex. PLoS Genetics, 4(12), e1000315. <http://doi.org/10.1371/journal.pgen.1000315>

Follit, J. A., Agustin, J. T. S., Xu, F., Jonassen, J. A., Samtani, R., Lo, C. W., & Pazour, G. J. (2008). The Golgin GMAP210/TRIP11 Anchors IFT20 to the Golgi Complex. PLoS Genetics, 4(12), e1000315. <http://doi.org/10.1371/journal.pgen.1000315>

In both cases, GMAP-210 deletion leads to embryonic death. Follit observed defects in cilium morphology and function through a decrease in Hedgehog signaling. Smits observed defects in skeletal tissue through decrease in perlican secretion. Although our aim was not to resolve these conflicting studies, our study suggests some hypotheses. First, the defect in perlecan secretion and glycosyslation contrasts with the normal fate of type II collagen and aggregan, which are much bigger matrix proteins. Given the ability of GMAP-210 to select vesicles based on their size, GMAP-210 deficiency should affect only matrix proteins that are incorporated into small classical transport vesicles. Second, the primary cilium has a different lipid composition than the plasma membrane in which it is embedded. Thanks to its ability to select transport vesicles according to their bulk lipid composition, GMAP-210 could help making this atypical membrane structure. These two hypotheses are presented in the new final paragraph of the Discussion.

2\) An unexpected observation is that the ALPS motif alone is targeted to the early Golgi, as if vesicles are accumulating there for interaction. Is this true in GMAP-210 depleted cells? Is this also true for the ALPs motif from ArfGAP1? Please elaborate. Please provide evidence that this really is the Golgi vs. a peri-Golgi compartment.

Thank you for this suggestion. To address these points, we have conducted new experiments in which the cells were first siRNA treated for 72 hrs to deplete GMAP-210 and then transiently transfected with probes expressing the ALPS motif. Alternatively, we used cells stably expressing ArfGAP1 (see Vanni et al. 2014 Nat Comm) and again treated the cell with GMAP-210 si RNA. These experiments are presented in a new figure ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). In both cases, the reporter (ArfGAP1 or the ALPS containing probe) remains localized at the Golgi in contrast with liposomes, which no longer accumulate ([Figure 2](#fig2){ref-type="fig"}). However, Lowe et al. noticed that depletion of GMAP-210 by siRNA causes vesicles to accumulate at the Golgi at the expense of Golgi cisternae. Probably the vesicles are taken in charge by the other golgins but the flow of vesicle capture and fusion is modified by GMAP-210 deletion (see [Figure 2](#fig2){ref-type="fig"} in Roboti et al). Therefore, there should be enough authentic vesicles for ALPS binding, which is what we observe. These new experiments are presented in a new paragraph of the Results section (subsection "Selective *cis* Golgi targeting of the ALPS motif of GMAP-210", fourth paragraph).

Since this observation does not allow us to connect the two central observations of our paper (the role of GMAP-210 in liposome capture and the targeting of the ALPS motif to the early Golgi), we performed a different experiment, which is shown in a new Figure ([Figure 4---figure supplement 2](#fig4s2){ref-type="fig"}). We perforated cells that over express the ALPS probe (ALPS-ACC1-GFP). We observed more liposome capture in these cells than in control cells. This observation complements the siRNA experiment ([Figure 2](#fig2){ref-type="fig"}) and indicates a correlation between liposome tethering activity of the Golgi and the amount of ALPS motif present. We present these new experiments in the Results section (subsection "Selective *cis* Golgi targeting of the ALPS motif of GMAP-210", last paragraph.

3\) The mitochondrial tethering experiment data in [Figure 3](#fig3){ref-type="fig"} could be better of quality. In [Figure 3C](#fig3){ref-type="fig"} it is not clear what are Golgi fragments versus mitochondria. The same applies for [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}. Additional counterstains for mitochondria and Golgi would clarify the results. Also, some controls seem missing. There should be \[no rapamycin+nocodazole\], which is the better control for the \[rapamycin+nocodazole\] samples. [Figure 7](#fig7){ref-type="fig"} and [Figure 7---figure supplement 1](#fig7s1){ref-type="fig"} also need counter staining for the Golgi. It is not possible to easily discern the Golgi from other membrane compartments without the Golgi counter labelling.

We acknowledge that the previous main figure lacked proper controls and that the use of only two colors (red for liposomes, green for the ALPS construct) made the analysis ambiguous without further staining of membrane compartments. In addition, the supplementary figure was a jumble of different controls.

As suggested by the reviewers, we now focus on two conditions in the main figure ([Figure 3](#fig3){ref-type="fig"}): + nocodazole -- rapamycin and + nocodazole + rapamycin. In the text, we better explain the advantage of using nocodazole to favor competition between Golgi mini stacks and mitochondria for vesicles capture (following the observation of Wong and Munro and of Sato et al.). In addition, three colors are now used: red: liposomes; green: the ALPS constructs; and violet: GM130 ([Figure 3](#fig3){ref-type="fig"}) or MitoTracker ([Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}). A second figure ([Figure 3---figure supplement 2](#fig3s2){ref-type="fig"}) shows the effect of liposome size on liposome capture through mitochondria-targeted ALPS. All figures also contain a small scheme to better explain the experimental conditions.

As for the quality of the images, we hope that the new ones are more satisfactory. However, and as explained in the legend of [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}, cell perforation clearly damages the mitochondria network, leaving remnants that are less connected and show a round shape.

As for [Figure 7](#fig7){ref-type="fig"} a new supplement figure now shows the counter staining for the Golgi ([Figure 7---figure supplement 2](#fig7s2){ref-type="fig"}).

4\) Results: \"GMAP-210 is responsible (for a large portion) of the ability of the Golgi\" (please modify). Are there other obvious candidate proteins that can explain the residual fluorescence detected over the Golgi in GMAP-210 depleted cells? Please discuss.

We have modified the sentence to temper our conclusion: "Altogether, the experiments shown in [Figure 2](#fig2){ref-type="fig"} indicate that GMAP-210 makes a major contribution to the liposome capture property of the Golgi" and added more information on this point in the Discussion (second paragraph).

Thus, we performed a new bioinformatics search for ALPS-like motifs considering all golgins described by Munro in a recent review. The following list shows the corresponding Uniprot entry numbers:

O60763, P82094, Q7Z5G4, Q8IWJ2, Q8TBA6, Q96CN9, Q08378, Q08379, Q13439, Q13948, Q14789, Q15643, Q92805

As before (Drin et al. 2007), we found an ALPS motif in the golgin giantin (entry: Q14789\|GOGB1_HUMAN Golgin subfamily). The corresponding sequence is: (2726)NKGLTAQIQSFGRSMSSLQNS(2746). This motif is localized within the coiled-coil region of this giant protein, about 500 a.a., apart from the transmembrane domain. As such, it might act as a binding site for small vesicles deeper in the golgin matrix as compared to the ALPS motif of GMAP-210, which resides at the N-terminus. However, the ALPS motif of giantin shows a moderate but significant probability to be folded as a coiled-coil. The potential role of this motif is now discussed (Discussion, second paragraph).

5\) [Figure 3C](#fig3){ref-type="fig"}. Why is nocodazole used? What happens if it is omitted? Also, given that the ALPS motif will capture endogenous small vesicles how can they be sure that the liposomes are not binding to these vesicles rather than directly to the ALPS motif?

See response to point 3.

*6) [Figure 6A](#fig6){ref-type="fig"}/C. It seems hard to reconcile the small effects seen by immunofluorescence with the large effects shown in the quantitation. This is in contrast with [Figure 6B](#fig6){ref-type="fig"} -- please explain.*

The reader eye focuses on the organelle displaying the highest fluorescence level. For quantification, however, we did only not consider the absolute fluorescence at the Golgi but instead the Golgi/cytosol ratio. For this, we divided the fluorescence in a 'Golgi box' by the fluorescence in a 'cytosol box' of the same surface. This method gives a fair estimate of the Golgi/cytosol partitioning of the various constructs and allows detecting modest changes between constructs that do decorate the Golgi but show different levels in the cytosol. However, we acknowledge that the image contrast was not optimal to appreciate some differences in the protein level in the cytosol. We have added a supplementary figure in gray levels to better illustrate this point ([Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}).
